OPTN - オプティノ―ズ (OptiNose Inc.) オプティノ―ズ

 OPTNのチャート


 OPTNの企業情報

symbol OPTN
会社名 OptiNose Inc (オプティノ―ズ)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 オプティノーズ(OptiNose Inc.)は製薬会社である。同社は、耳、鼻、咽喉、またはENT、及びアレルギーの専門家によって治療された患者のための製品の開発・商品化に従事する。同社の製品候補には、XHANCE(鼻ポリープ)、チャンス(慢性副鼻腔炎)OPN-300、OPN-021などがある。主力製品であるXHANCE(プロピオン酸フルチカゾン)の鼻スプレーは、鼻ポリープを伴う慢性鼻副鼻腔炎の治療用局所的に作用し強力な抗炎症性コルチコステロイドを送達するために、呼吸動力呼気供給システム(EDS)を利用する。XHANCEは、炎症の原発部位に薬物を送達することができるため、この疾患の治療基準の一部となる可能性を有する差別化された臨床プロファイルを有する。   オプティノ―ズは米国の専門医薬品企業。主に耳鼻咽喉科の疾患に対する治療薬の開発・商業化に従事する。同社製品には鼻ポリ―プの有無に関わらず慢性鼻副鼻腔炎の治療用に、局所作用の抗炎症性コルチコステロイドを送達する呼気供給システムの「XHANCE」を含む。また、偏頭痛の治療薬「AVP-825」を販売する。本社所在地はペンシルベニア州ヤ―ドレ―。   OptiNose, Inc. operates as a pharmaceutical company. The firm engages in the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists. Its products include the XHANCE and ONZETRA Xsail. The company was founded by Per Gisle Djupesland and Helena Kyttari Djupesland in October 2000 and is headquartered in Yardley, PA.
本社所在地 1020 Stony Hill Road Suite 300 Yardley PA 19067 USA
代表者氏名 Joseph C. Scodari ジョセフ・C.スコダリ
代表者役職名 Independent Chairman of the Board
電話番号 +1 267-364-3500
設立年月日 40299
市場名 NASDAQ National Market System
ipoyear 2017年
従業員数 82人
url www.optinose.com
nasdaq_url https://www.nasdaq.com/symbol/optn
adr_tso
EBITDA EBITDA(百万ドル) -84.65000
終値(lastsale) 10.66
時価総額(marketcap) 439411958.44
時価総額 時価総額(百万ドル) 469.50300
売上高 売上高(百万ドル) 2.13900
企業価値(EV) 企業価値(EV)(百万ドル) 296.65100
当期純利益 当期純利益(百万ドル) -92.61300
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 OptiNose Inc revenues increased from $0K to $2.1M. Net loss applicable to common stockholders increased from $24.5M to $55.2M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Selling general and administrative increase from $6.1M to $46.2M (expense) Interest expense increase from $862K to $4.5M (expense).

 OPTNのテクニカル分析


 OPTNのニュース

   OptiNose Inc (NASDAQ:OPTN) Expected to Post Earnings of -$0.56 Per Share  2020/10/24 14:06:56 Zolmax News
Equities analysts expect OptiNose Inc (NASDAQ:OPTN) to post ($0.56) earnings per share (EPS) for the current fiscal quarter, Zacks reports. Two analysts have provided estimates for OptiNose’s earnings, with estimates ranging from ($0.63) to ($0.48). OptiNose posted earnings per share of ($0.69) during the same quarter last year, which suggests a positive year-over-year growth rate […]
   Brokerages Expect OptiNose Inc (NASDAQ:OPTN) Will Post Quarterly Sales of $14.69 Million  2020/10/23 02:48:41 US Banking News
Brokerages forecast that OptiNose Inc (NASDAQ:OPTN) will post sales of $14.69 million for the current fiscal quarter, according to Zacks. Two analysts have issued estimates for OptiNose’s earnings, with the lowest sales estimate coming in at $13.60 million and the highest estimate coming in at $15.78 million. OptiNose reported sales of $12.40 million during the […]
   OptiNose Inc (NASDAQ:OPTN) Expected to Post Quarterly Sales of $14.69 Million  2020/10/23 02:48:41 US Banking News
Brokerages predict that OptiNose Inc (NASDAQ:OPTN) will report $14.69 million in sales for the current fiscal quarter, according to Zacks. Two analysts have issued estimates for OptiNose’s earnings, with estimates ranging from $13.60 million to $15.78 million. OptiNose posted sales of $12.40 million in the same quarter last year, which suggests a positive year over […]
   Zacks: Brokerages Expect OptiNose Inc (NASDAQ:OPTN) Will Announce Earnings of -$0.56 Per Share  2020/10/21 13:41:00 Transcript Daily
Analysts forecast that OptiNose Inc (NASDAQ:OPTN) will announce earnings per share of ($0.56) for the current fiscal quarter, according to Zacks Investment Research. Two analysts have issued estimates for OptiNose’s earnings, with the lowest EPS estimate coming in at ($0.63) and the highest estimate coming in at ($0.48). OptiNose posted earnings per share of ($0.69) […]
   New Peer-Reviewed Data Highlight the Benefits of XHANCE in Patients Who Remain Symptomatic After Treatment with Standard Nasal Steroid Sprays  2020/09/29 13:30:00 PR Newswire
YARDLEY, Pa., Sept. 29, 2020 /PRNewswire/ -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced the peer-review publication of a paper titled, "Efficacy of the exhalation delivery system with…
   Optinose Reports Second Quarter 2020 Financial Results and Recent Operational Highlights  2020/08/04 07:00:00 Benzinga
Company reports second quarter 2020 XHANCE net revenue of $10.3 million Second quarter 2020 XHANCE prescriptions increased 84% from second quarter …
   Optinose Announces Reporting Date for Second Quarter 2020 Financial Results  2020/07/30 20:01:00 GlobeNewswire
YARDLEY, Pa., July 30, 2020 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat…
   Is OptiNose the Next Big Coronavirus Stock?  2020/06/30 15:55:18 24/7 Wall street
   ViewRay and NantKwest among healthcare gainers; Zynerba Pharmaceuticals leads the losers  2020/06/30 15:04:21 Seeking Alpha
Gainers: Calliditas Therapeutics (NASDAQ:CALT) +20%. ViewRay (NASDAQ:VRAY) +19%. Anixa Biosciences (NASDAQ:ANIX) +19%. OptiNose (NASDAQ:OPTN) +18%. NantKwe
   Optinose to Report First Quarter 2020 Financial Results and Corporate Updates on May 7, 2020  2020/04/30 20:15:00 GlobeNewswire
Conference Call and Webcast Scheduled for Thursday, May 7 at 4:15 p.m. Eastern Time YARDLEY, Pa., April 30, 2020 (GLOBE NEWSWIRE) -- Optinose…
   Is OptiNose the Next Big Coronavirus Stock?  2020/06/30 15:55:18 24/7 Wall street
   ViewRay and NantKwest among healthcare gainers; Zynerba Pharmaceuticals leads the losers  2020/06/30 15:04:21 Seeking Alpha
Gainers: Calliditas Therapeutics (NASDAQ:CALT) +20%. ViewRay (NASDAQ:VRAY) +19%. Anixa Biosciences (NASDAQ:ANIX) +19%. OptiNose (NASDAQ:OPTN) +18%. NantKwe
   Optinose to Report First Quarter 2020 Financial Results and Corporate Updates on May 7, 2020  2020/04/30 20:15:00 GlobeNewswire
Conference Call and Webcast Scheduled for Thursday, May 7 at 4:15 p.m. Eastern Time YARDLEY, Pa., April 30, 2020 (GLOBE NEWSWIRE) -- Optinose…
   11 major companies that have returned millions of dollars acquired through a government relief program meant for small businesses  2020/04/27 22:13:00 Business Insider
The $349 billion Paycheck Protection Program launched in early April was meant to bolster struggling small businesses . It was aimed at providing businesses with fewer than 500 employees with two-year, low-interest loans to cover salaries, wages, benefits, and certain taxes. The program would provide up to $10 million per company. Hundreds of publicly traded companies received funding through the federal government's Paycheck Protection Program. The program ran out of money less than two weeks after it was introduced. On April 23, the Treasury Department said publicly traded companies have two weeks to give back federal relief loans intended for small businesses. Here is a list of major companies, from Shake Shack to AutoNation, that have already confirmed they're returning the funds. Visit Business Insider's homepage for more stories . This is a developing story. Check back for updates. SEE ALSO: The coronavirus outbreak has triggered unprecedented mass layoffs and furloughs. Here are the major companies that have announced they are downsizing their workforces.
   Moving Average Crossover Alert: OptiNose  2020/03/16 13:15:00 Zacks Investment Research
OptiNose, Inc. (OPTN) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 オプティノ―ズ OPTN OptiNose Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)